HCA Reports Second Quarter 2017 Results

Go back to HCA Reports Second Quarter 2017 Results

HCA Holdings (HCA) PT Lowered to $92 at Mizuho Securities; Reiterates Buy

July 26, 2017 7:17 AM EDT

Mizuho Securities lowered its price target on HCA Holdings (NYSE: HCA) to $92.00 (from $98.00) while maintaining a Buy rating. Analyst Sheryl Skolnick still believes that HCA can still preserve margin in 2018, can still grow the top line and can generate around 4% EBITDA... More

HCA Holdings (HCA) Misses Q2 EPS by 6c

July 25, 2017 8:31 AM EDT

HCA Holdings (NYSE: HCA) reported Q2 EPS of $1.75, $0.06 worse than the analyst estimate of $1.81. Revenue for the quarter came in at $10.73 billion versus the consensus estimate of $10.85 billion.

Revenues increased 4.0 percent to $10.733 billionNet income attributable to HCA Healthcare, Inc. totaled $657 million, or $1.75 per... More